Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 07 Jan 2026 for Cidara Therapeutics, Inc., €2.4M.
Filing timeline
BuySaleNicole Negar Davarpanah
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Nicole Negar Davarpanah: trading record in brief
Nicole Negar Davarpanah appears in our data through filings on Cidara Therapeutics, Inc. shares, published by SEC (Form 4). In total, 6 filings cover trades dated from 1 May 2025 to 7 January 2026.
Every open-market trade on record is a sale: 1 sale worth €25k. Outside the open market, there are 2 share grants.
Most recently, on 7 January 2026, the filings show a transaction in Cidara Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nicole Negar Davarpanah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
12,553 shares@ US$221.5054.6% of flowCommon StockSEC:0002067554-26-000002:0
450 shares0Common StockSEC:0002067554-25-000004:0
10,332 shares@ US$219.6044.8% of flowCommon StockSEC:0001610618-25-000098:0
474 shares@ US$62.86270.6% of flowCommon StockSEC:0001610618-25-000086:0
10,000 shares0Common StockSEC:0001610618-25-000051:0
5 of 5 declarations
